It has been suggested that type I silent corticotroph adenomas have lower levels of MGMT than clinically active ACTH-secreting tumors (56), then, they could be good candidates for TMZ treatment. The gene discussed is MGMT; the disease is ACTH-producing pituitary gland adenoma.